ENGN News & Events

The major averages finished sharply higher following a preliminary U.S.-Iran peace agreement that could reopen the Strait of Hormuz and significantly ease pressure on global energy markets. Brent crude oil prices have dropped to roughly three-month lows after the announced agreement, easing concerns about supply disruptions and helping reduce inflation fears that had weighed on stocks throughout the spring.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Fox Corp.Rokufor $160 per shareSalesforcecustomer agent company Fin for $3.6BNuveiPayoneer Globalfor $7.40 per share in cash, or $2.75BTripAdvisorto American Expressfor $700M in cashThe U.K. government isfor children under the age of 162. WALL STREET CALLS:TruistDatadogto Buy, sees opportunity for continued upsideOld Dominionto Sell at CitiKeyBancFireFly Aerospaceand Rocket Labto Overweight after their SpaceX related selloffsAccentureto Equal Weight at Morgan StanleyFerrarito Overweight at Morgan Stanley3. AROUND THE WEB:Centeneis offering voluntary buyouts to most employees, Bloomberg reportsTeslarecently presented self-published safety statistics to regulators in Sweden and Netherlands, but independent traffic-safety researchers argue the statistics are misleading marketing, Reuters saysMatt Holt's investment firm Thoreau Group, which is backed by Apollo Global, is in advanced discussions to acquire Ensemble Health Partners in a deal that would value the company at roughly $12B, Bloomberg saysSBA Communications'potential take-private process involving KKRand Brookfieldhas stalled and is now considered effectively dead, as negotiations have come to a standstill in recent weeks, sources tell GreenstreetAccording to an Indian pollution regulator, wastewater from a Tata components factory for Apple'siPhone has allegedly contaminated groundwater, impacting nearby farms, Reuters says4. MOVERS:Oustergained afterwith Benchmark ElectronicsIntellia Therapeuticsincreased after presenting resultsStriveclosed higher afterand reporting holdings of 19,105 as of June 12Pattern Groupfinished lower afterAlcoafell after announcing the ratification of a5. EARNINGS/GUIDANCE:PowerFleet, with EPS and revenue beating consensusCoda Octopus, with EPS higher year-over-yearFiservbacked itsenGene, with EPS beating consensusJerash Holdingsand provided guidance for Q1INDEXES:The Dow rose 468.77, or 0.92%, to 51,671.03, the Nasdaq gained 795.10, or 3.07%, to 26,683.94, and the S&P 500 advanced 122.83, or 1.65%, to 7,554.29.

The major averages were sharply higher near noon as investors return from the weekend focused on a preliminary U.S.-Iran peace agreement that could reopen the Strait of Hormuz and significantly ease pressure on global energy markets. Brent crude oil prices have dropped to roughly three-month lows after the announced agreement, easing concerns about supply disruptions and helping reduce inflation fears that had weighed on stocks throughout the spring.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Fox Corp.Rokufor $160 per shareSalesforcecustomer agent company Fin for $3.6BNuveiPayoneer Globalfor $7.40 per share in cash, or $2.75BTripAdvisorwillto American Expressfor $700M in cashThe U.K. government isfor children under the age of 162. WALL STREET CALLS:TruistDatadogto Buy, sees opportunity for continued upsideOld Dominionto Sell at CitiKeyBancFireFly Aerospaceand Rocket Labto Overweight after their SpaceX related selloffsAccentureto Equal Weight at Morgan StanleyFerrarito Overweight at Morgan Stanley3. AROUND THE WEB:CommerzbankCEO Bettina Orlopp said the bank was surprised by allegations from UniCreditthat it had misled the public, highlighting rising tensions between the two banks, Reuters saysTeslarecently presented self-published safety statistics to regulators in Sweden and Netherlands, but independent traffic-safety researchers argue the statistics are misleading marketing, Reuters saysMatt Holt's investment firm Thoreau Group, which is backed by Apollo Global, is in advanced discussions to acquire Ensemble Health Partners in a deal that would value the company at roughly $12B, Bloomberg saysSBA Communications'potential take-private process involving KKRand Brookfieldhas stalled and is now considered effectively dead, as negotiations have come to a standstill in recent weeks, sources tell GreenstreetAccording to an Indian pollution regulator, wastewater from a Tata components factory for Apple'siPhone has allegedly contaminated groundwater, impacting nearby farms, Reuters says4. MOVERS:Oustergains afterwith Benchmark ElectronicsIntellia Therapeuticsincreases afterfrom its Phase 3 HAELO trialStrivehigher afterand reporting holdings of 19,105 as of June 12Pattern Grouplower after filing toAlcoafalls after announcing the ratification of awith USW5. EARNINGS/GUIDANCE:PowerFleet, with EPS and revenue beating consensusCoda Octopus, with EPS higher year-over-yearFiservfor FY26enGene, with EPS beating consensusJerash Holdingsand provided guidance for Q1INDEXES:Near midday, the Dow was up 1.37%, or 703.88, to 51,906.14, the Nasdaq was up 2.99%, or 773.00, to 26,661.85, and the S&P 500 was up 1.91%, or 141.58, to 7,573.04.

In June, enGene implemented a plan to reduce its workforce by approximately 50% to streamline operations and preserve cash. The Company has retained personnel and resources required to meet its key strategic goals and milestones, including completion of LEGEND Cohort 1; enrolling the detalimogene plus surfactant cohort; meeting with the FDA and planning for BLA initiation in 2H 2026; and completing necessary pre-commercial activities required to support the planned commercial launch of detalimogene in 2027. In conjunction with its reduction in force, the following executive officers will depart from the Company, effective July 15: Ryan Daws, CFO, Lee Giguere, CLO and Alex Nichols, Chief Strategy and Operations Officer. Anthony Cheung, Chief Scientific Officer, will continue in his role through September 30, 2026, after which, he will transition into a consulting arrangement. Hussein Sweiti, M.D., Chief Medical Officer, stepped down from his position to pursue a new professional opportunity, effective June 14. Effective immediately, William Grossman, M.D., Ph.D., a member of enGene's Board of Directors, will act as interim CMO. He is the former Senior Vice President and Therapeutic Area Head of Oncology Clinical Development at Gilead Sciences. Constantine Chinoporos, who joined the Company in May as a business development consultant, is expected to act as enGene's interim Chief Business Officer